-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLDEX THERAPEUTICS SHARES FALL 3% AFTER THE BELL FOLLOWING PHASE 2 STUDY RESULTS

Reuters·11/19/2026 21:38:26

Please log in to view news